LTLisa M. Tuttle

Lisa M. Tuttle

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lisa M. Tuttle has a total of 78 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Ultraslow conformational dynamics and catch bond formation of a bacterial adhesin revealed by a single-domain variant of FimH

    by Pearl Magala, Lisa M. Tuttle, Gianluca Interlandi, Laura A. Carlucci, Molly Y. Mollica, Maria K. Janowska, Wendy E. Thomas, Evgeni V. Sokurenko, Rachel E. Klevit

    Bacterial fimbrial adhesins such as FimH are critical for host colonization and persistence under the mechanical forces encountered at sites of infection such as the urinary tract. The molecular mechanisms by which FimH, a key virulence factor of uropathogenic Escherichia coli , regulates its binding to host cell surface mannose moieties through conformational switching remain incompletely understood. FimH operates across a range of conformations that includes low- (LAS), intermediate-, and high-affinity (HAS) states and forms catch bonds that paradoxically strengthen under force. The allosteric pathways governing these transitions remain poorly defined due to experimental limitations that restrict understanding of key dynamic phenomena that underlie ligand-triggered conformational shifts and force-induced long-lived interactions. Such understanding is central to drug discovery efforts to target bacterial adhesion. Here, we present a model system that fully recapitulates the conformational repertoire of FimH in the absence of its pilin domain. Our findings demonstrate that a single mutation in the lectin domain stabilizes the LAS while allowing for ligand-binding-induced transition to a HAS-like conformation and catch bond formation, mirroring the behavior of the native FimH adhesin. We propose a dynamic allosteric mechanism that involves ultraslow, low-frequency dynamics for the ability of FimH to sustain long-lived interactions with mannose, under both static and force conditions.


  • Open Access

    Disorder with consequence: Phosphorylation sites in HSPB5 yield distinct structural outcomes

    by Natalie L. Stone, Maria K. Janowska, Lucas Narisawa, Lisa M. Tuttle, Lindsey D. Ulmer, Miklos Guttman, Matthew F. Bush, Rachel E. Klevit

    HSPB5, a member of the small heat shock protein family, acts as a first responder to cellular stress. One proposed mechanism of stress activation is phosphorylation. HSPB5 is phosphorylated at three sites—serine residues at positions 19, 45, and 59—located within its disordered N-terminal region (NTR). The extent of phosphorylation of the different sites leads to different cellular outcomes. HSPB5 forms polydisperse oligomers, where the NTR regions can either be exposed to the solvent or buried within the oligomer, forming internal contacts. We assessed the effect of single and triple phospho-mimicry on HSPB5 oligomeric properties. Our findings indicate that single phosphorylation causes localized and subtle changes in oligomer size, subunit exchange, hydrogen-deuterium protection patterns, and ability to delay aggregation of a known eye lens client, γD-crystallin. In contrast, the triple phosphomimic shows substantial structural and functional alterations. We provide a rationale for the increased chaperone activity observed in the S45D phosphomimic. Taken together, our results offer structural insights into how different phosphorylation events lead to distinct cellular outcomes.

  • Open Access

    Mapping Hydrogen Migration Thresholds for Site-Specific HDX-MS

    by Charles C. Mundorff, Sarah Hadley, Lisa M. Tuttle, Yuqi Shi, Graeme C. McAlister, Rosa Viner, Rachel E. Klevit, Miklos Guttman


  • Open Access

    Ultra-slow conformational dynamics and catch bond formation of a Bacterial Adhesin revealed by a single-domain variant of FimH

    by Pearl Magala, Lisa M. Tuttle, Gianluca Interlandi, Laura A. Carlucci, Molly Y. Mollica, Maria K. Janowska, Wendy E. Thomas, Evgeni V. Sokurenko, Rachel E. Klevit

    Bacterial adhesins such as FimH are critical for host colonization and persistence under the mechanical forces encountered at sites of infection such as the urinary tract. Despite decades of research, the molecular mechanisms by which FimH—a key virulence factor of Escherichia coli —regulates its binding through conformational switching remain incompletely understood. FimH operates across a range of conformations that includes low- (LAS), intermediate-, high-affinity (HAS) states-- and forms catch bonds which paradoxically strengthen under force. The allosteric pathways governing these transitions remain poorly defined due to experimental limitations that restrict understanding of key dynamic phenomena that underlie ligand-triggered conformational shifts and force-induced long-lived interactions. Such understanding is central to drug discovery efforts to target bacterial adhesion. Here we present a model system that fully recapitulates the conformational repertoire of FimH in the absence of its pilin domain. Our findings demonstrate that a single mutation in the lectin domain induces the LAS while allowing for ligand-binding induced conformational change to the HAS and catch bond formation, mirroring the behavior of the native FimH adhesin. We propose a dynamic allosteric mechanism that involves ultra-slow, low-frequency dynamics for the ability of FimH and the bacteria that express it, to sustain long-lived interactions with mannose under both static and force conditions. Significance: Urinary tract infections (UTIs) are among the most common bacterial infections, and their initiation depends on the ability of uropathogenic Escherichia coli (UPEC) to adhere to bladder cells. The adhesion is mediated by FimH, a protein on the outside of UPEC that binds mannose-containing glycoprotein receptors and strengthens its grip under shear stress via a catch-bond mechanism. To investigate FimH function, we engineered a variant that can adopt both low- and high-affinity states of FimH and can form catch bonds. We discovered that FimH is governed by ultra-slow conformational dynamics that vary even among structurally similar states. These findings provide a mechanistic framework for developing anti-adhesive therapies that target FimH dynamics, offering a novel strategy to prevent and treat UTIs.

  • Open Access

    A framework for automated multimodal HDX-MS analysis

    by Lisa M. Tuttle, Rachel E. Klevit, Miklos Guttman

    We present pyHXExpress, a customizable codebase for automated high-throughput multimodal analysis of all spectra generated from HDX-MS experiments. The workflow was validated against a synthetic test dataset to test the fitting algorithms and to confirm the statistical outputs. We further establish a framework for the determination of multimodality throughout a protein system by rigorous evaluation of multimodal fits across all peptide spectra. We demonstrate this approach using entire protein datasets to detect multimodality, conformational heterogeneity, and characterize dynamics of small heat shock protein HSPB5 and two disease mutants.


  • Rigorous Analysis of Multimodal HDX-MS Spectra

    by Lisa M. Tuttle, Ellie I. James, Florian Georgescauld, Thomas E. Wales, David D. Weis, John R. Engen, Abhinav Nath, Rachel E. Klevit, Miklos Guttman

    An inherent strength of hydrogen/deuterium exchange coupled to mass spectrometry (HDX-MS) is its ability to detect the presence of multiple conformational states of a protein, which often manifest as multimodal isotopic envelopes. However, the statistical considerations for accurate analysis of multimodal spectra have yet to be established. Here we outline an unrestrained binomial distribution fitting approach with the corresponding statistical tests to accurately detect and, when possible, deconvolute isotopic distributions that contain multiple subpopulations. The algorithms have been incorporated into an updated version of the freely available software, HX-Express, and validated using known mixtures of peptides deuterated to varying degrees. This approach presents a readily accessible tool to fit and interpret bimodal and trimodal behavior in HDX-MS data for mixed populations, EX1 kinetics, and pulse labeling data.


  • BRCA1/BARD1 intrinsically disordered regions facilitate chromatin recruitment and ubiquitylation

    by Samuel R Witus, Lisa M Tuttle, Wenjing Li, Alex Zelter, Meiling Wang, Klaiten E Kermoade, Damien B Wilburn, Trisha N Davis, Peter S Brzovic, Weixing Zhao, et al.

    BRCA1/BARD1 is a tumor suppressor E3 ubiquitin (Ub) ligase with roles in DNA damage repair and in transcriptional regulation. BRCA1/BARD1 RING domains interact with nucleosomes to facilitate mono-ubiquitylation of distinct residues on the C-terminal tail of histone H2A. These enzymatic domains constitute a small fraction of the heterodimer, raising the possibility of functional chromatin interactions involving other regions such as the BARD1 C-terminal domains that bind nucleosomes containing the DNA damage signal H2A K15-Ub and H4 K20me0, or portions of the expansive intrinsically disordered regions found in both subunits. Herein, we reveal novel interactions that support robust H2A ubiquitylation activity mediated through a high-affinity, intrinsically disordered DNA-binding region of BARD1. These interactions support BRCA1/BARD1 recruitment to chromatin and sites of DNA damage in cells and contribute to their survival. We also reveal distinct BRCA1/BARD1 complexes that depend on the presence of H2A K15-Ub, including a complex where a single BARD1 subunit spans adjacent nucleosome units. Our findings identify an extensive network of multivalent BARD1-nucleosome interactions that serve as a platform for BRCA1/BARD1-associated functions on chromatin.


  • Open Access

    BRCA1/BARD1 intrinsically disordered regions facilitate chromatin recruitment and ubiquitylation

    by Samuel R. Witus, Lisa M. Tuttle, Wenjing Li, Alex Zelter, Meiling Wang, Klaiten E. Kermoade, Damien B. Wilburn, Trisha N. Davis, Peter S. Brzovic, Weixing Zhao, et al.

    BRCA1/BARD1 is a tumor suppressor E3 ubiquitin (Ub) ligase with roles in DNA damage repair and in transcriptional regulation. BRCA1/BARD1 RING domains interact with nucleosomes to facilitate mono-ubiquitylation of distinct residues on the C-terminal tail of histone H2A. These enzymatic domains constitute a small fraction of the heterodimer, raising the possibility of functional chromatin interactions involving other regions such as the BARD1 C-terminal domains that bind nucleosomes containing the DNA damage signal H2A K15-Ub and H4 K20me0, or portions of the expansive intrinsically disordered regions found in both subunits. Herein, we reveal novel interactions that support robust H2A ubiquitylation activity mediated through a high-affinity, intrinsically disordered DNA-binding region of BARD1. These interactions support BRCA1/BARD1 recruitment to chromatin and sites of DNA damage in cells and contribute to their survival. We also reveal distinct BRCA1/BARD1 complexes that depend on the presence of H2A K15-Ub, including a complex where a single BARD1 subunit spans adjacent nucleosome units. Our findings identify an extensive network of multivalent BARD1- nucleosome interactions that serve as a platform for BRCA1/BARD1-associated functions on chromatin.


  • Open Access

    Mediator subunit Med15 dictates the conserved “fuzzy” binding mechanism of yeast transcription activators Gal4 and Gcn4

    by Lisa M. Tuttle, Derek Pacheco, Linda Warfield, Damien B. Wilburn, Steven Hahn, Rachel E. Klevit

    The acidic activation domain (AD) of yeast transcription factor Gal4 plays a dual role in transcription repression and activation through binding to Gal80 repressor and Mediator subunit Med15. The activation function of Gal4 arises from two hydrophobic regions within the 40-residue AD. We show by NMR that each AD region binds the Mediator subunit Med15 using a “fuzzy” protein interface. Remarkably, comparison of chemical shift perturbations shows that Gal4 and Gcn4, two intrinsically disordered ADs of different sequence, interact nearly identically with Med15. The finding that two ADs of different sequence use an identical fuzzy binding mechanism shows a common sequence-independent mechanism for AD-Mediator binding, similar to interactions within a hydrophobic cloud. In contrast, the same region of Gal4 AD interacts strongly with Gal80 via a distinct structured complex, implying that the structured binding partner of an intrinsically disordered protein dictates the type of protein–protein interaction.


  • BRCA1/BARD1 site-specific ubiquitylation of nucleosomal H2A is directed by BARD1

    by Samuel R. Witus, Anika L. Burrell, Daniel P. Farrell, Jianming Kang, Meiling Wang, Jesse M. Hansen, Alex Pravat, Lisa M. Tuttle, Mikaela D. Stewart, Peter S. Brzovic, et al.

    Mutations in the E3 ubiquitin ligase RING domains of BRCA1/BARD1 predispose carriers to breast and ovarian cancers. We present the structure of the BRCA1/BARD1 RING heterodimer with the E2 enzyme UbcH5c bound to its cellular target, the nucleosome, along with biochemical data that explain how the complex selectively ubiquitylates lysines 125, 127 and 129 in the flexible C-terminal tail of H2A in a fully human system. The structure reveals that a novel BARD1-histone interface couples to a repositioning of UbcH5c compared to the structurally similar PRC1 E3 ligase Ring1b/Bmi1 that ubiquitylates H2A Lys119 in nucleosomes. This interface is sensitive to both H3 Lys79 methylation status and mutations found in individuals with cancer. Furthermore, NMR reveals an unexpected mode of E3-mediated substrate regulation through modulation of dynamics in the C-terminal tail of H2A. Our findings provide insight into how E3 ligases preferentially target nearby lysine residues in nucleosomes by a steric occlusion and distancing mechanism.